Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Legalon for Non-Alcoholic Steatohepatitis (SyNCH)
NCT00680407Phase 2Completed
- Sponsor
- Madaus GmbH
- Start
- Apr 2008
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silibinin in Nonalcoholic steatohepatitis (NASH), sponsored by Madaus GmbH. Started Apr 2008; status: completed.
02
Drugs
silibinin
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT00680407.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00680407.